Research at the Stanford Stroke Center

Marion Buckwalter, MD PhD in the lab

The Stanford Stroke Center has consistently been one of the most prolific stroke research groups in the United States; faculty members have published more than 600 manuscripts based on clinical stroke research, as well as hundreds of basic science studies; the Center has maintained continuous NIH grant support for over 20 years. Stroke Center faculty members have authored more than 20 national and international clinical guideline statements. Stanford has pioneered major advances in medical therapies for treating and preventing stroke, neurosurgical techniques for stroke prevention, and novel interventional neuroradiologic procedures for stroke patients. The Center developed an innovative TIA program that is transforming the way TIA is diagnosed and managed. The Neurocritical Care Program has made key advances in the diagnosis of intracerebral hemorrhage and the prognosis of coma. Stanford neuroscientists have helped clarify the basic mechanisms of stroke-induced brain injury and have pioneered several new imaging techniques that facilitate the identification of salvageable ischemic brain tissue in patients presenting with an acute stroke. Stroke recovery research, including participation in 3 early clinical stem cell therapy trials and development of a new line of stem cells, has also been a focus area.